Latest treating cancer Stories
Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting explores treatment with a newly developed type of radioimmunotherapy used for treating a resistant form of kidney cancer.
Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells.
A research group in the Faculty of Medicine & Dentistry at the University of Alberta is hoping its latest discovery could one day be used to develop new therapies that target certain types of cancers.
Colorectal cancer is the third most commonly diagnosed cancer in the Unites States, and the third leading cause of cancer death.
Clinical trials for a new bladder cancer therapy show promising interim results.
Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why the drug is also effective as a cancer therapy.
Fear of nausea a significant issue and often not discussed with healthcare providers CALIFON, NJ, April 25 /PRNewswire/ - PediatRx, Inc.
BOZEN, Sud-Tirol, Italy, March 7, 2011 /PRNewswire/ -- Health Robotics today announced the completion of its initial research, development, and factory-testing activities for its next-generation Cancer Therapy Robot, i.v.STATION ONCO, and its unveiling at the European Association of Hospital Pharmacists (EAHP) in Vienna on 1 April 2011, including its new overpowering features: four times faster, five times smaller, and three times less expensive than some of the other Sterile Compounding...
- A political dynamiter.